MAY 08, 2018 6:47 PM PDT

Promising Treatment for Alcoholism

WRITTEN BY: Nouran Amin

Investigators at the University of Texas at Austin have successfully used animal models to examine a drug believed to inhibit the symptoms of alcohol withdrawal, ultimately treating alcoholism.

Alcoholism is a chronic disease affecting more than 15 million Americans and many more across the globe. More specifically, it is a disease characterized by the preoccupation of alcohol. Although there exists an array of drugs to combat alcohol addiction, they are not always effective and tend to have negative side effects.

Now, the drug believed to treat alcohol addiction known as JVW-1034, was studied to work in worms and rats that exhibited symptoms of alcohol addiction. These results can eventually be illustrated in human patients with little to no side effects. However, UT-Austin researchers noted that the drug will need to go through intensive monitoring before any clinical trials on humans can occur.

JVW-1034 is unique because it works to inhibit an unconventional molecular pathway that produces no side effects. “There’s clearly a huge need for something different and better,” explains UT Austin researchers and co-author of the study, James Sahn. “That’s where our approach shines. It’s modulating a pathway that doesn’t seem to be associated with any of the other drugs that are available.”

Although JVW-1034 is promising, researchers are hoping to optimize the efficacy of the drugs chemical properties. They are planning to create a pill that can someday be able to block alcohol withdrawal symptoms and alcohol cravings in order to help affected individuals avoid relapse. Unfortunately, a creation of such pill is still unclear in its promise to treat alcoholism. This is primarily because alcoholism is a complex disease with a multitude of factors that may contribute to its pathophysiology. Regardless, a drug taken for a chronic disease can still be effective in treating stress and being beneficial for individuals affected by alcoholism.

“If we could achieve a medication that is effective for more people and doesn’t have the negative side effects that some of these drugs have, that would be game-changing,” says Stephen Martin, professor of chemistry at UT Austin and senior author.

Sources: University of Texas at Austin, Neuropsychopharmacology

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 08, 2020
Neuroscience
Psychedelic DMT Improves Memory by Neurogenesis
NOV 08, 2020
Psychedelic DMT Improves Memory by Neurogenesis
Researchers from the Complutense University of Madrid in Spain have found that dimethyltryptamine (DMT), the psychoactiv ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
NOV 16, 2020
Drug Discovery & Development
A Change of Heart
NOV 16, 2020
A Change of Heart
For a long time cardiovascular issues related to the heart muscular wall have been addressed by therapeutics that target ...
DEC 04, 2020
Drug Discovery & Development
OTC Drug Found Safe for Multiple Myeloma
DEC 04, 2020
OTC Drug Found Safe for Multiple Myeloma
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
Loading Comments...